AI for early detection of cancer return after treatment
Part of Cancer, Digestive system clinical trials.
This study is testing whether an artificial intelligence system can find very small amounts of leftover cancer (minimal residual disease) after treatment for rectal or esophageal cancer. If successful, this could help doctors detect a relapse earlier than current methods.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with rectal or esophageal cancer (confirmed by a biopsy).
- Your treatment plan includes surgery to remove the cancer with the goal of a cure.
- You will receive standard chemotherapy or radiation before or after surgery.
- You can give permission to use your blood and medical information for research.
- You agree to give blood samples before treatment, at 3 months, and at 6 months after treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares how an artificial intelligence system and a team of cancer doctors recommend treatment for rectal cancer. By understanding how well they agree, researchers hope to improve cancer treatment planning.
This trial tests an artificial-intelligence support tool that helps surgeons make decisions during surgery for rectal cancer. If you qualify, the tool may be used alongside the surgical team to support safer, more effective care.
This study uses an AI computer program to read special MRI images and predict how well treatment (given before surgery) will work for people with locally advanced rectal cancer. It may help doctors better plan who benefits most from neoadjuvant therapy (treatment before surgery).
This study tests an AI system that helps identify cancer or polyp findings during rectal surgery or assessment, using real-time information. It may help surgeons classify tissue more accurately while you are already getting treatment.
This trial is testing a computer model that helps doctors predict how difficult rectal cancer surgery will be, so they can choose the best approach. The study aims to improve surgical planning and outcomes for patients.
This study uses artificial intelligence to look at your MRI scans, tissue samples, and medical records to learn more about prostate cancer and find better ways to treat it. You may join if you've had prostate removal surgery or have advanced prostate cancer.
Hear when a new Rectal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.